BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8900045)

  • 1. Monoclonal antimyogenin antibodies define epitopes outside the bHLH domain where binding interferes with protein-protein and protein-DNA interactions.
    Wright WE; Dac-Korytko I; Farmer K
    Dev Genet; 1996; 19(2):131-8. PubMed ID: 8900045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the myogenic determination factor myogenin with E12 and a DNA target: mechanism and kinetics.
    Spinner DS; Liu S; Wang SW; Schmidt J
    J Mol Biol; 2002 Mar; 317(3):431-45. PubMed ID: 11922675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimeric structures influence the binding activity of bHLH muscle regulatory factors.
    Wright WE; Catala F; Farmer K
    Symp Soc Exp Biol; 1992; 46():79-87. PubMed ID: 1341052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of DNA sequence in the binding specificity of synthetic basic-helix-loop-helix domains.
    Beltran AC; Dawson PE; Gottesfeld JM
    Chembiochem; 2005 Jan; 6(1):104-13. PubMed ID: 15593070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MyoD-E12 heterodimers and MyoD-MyoD homodimers are equally stable.
    Maleki SJ; Royer CA; Hurlburt BK
    Biochemistry; 1997 Jun; 36(22):6762-7. PubMed ID: 9184158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The basic helix-loop-helix domain of the E47 transcription factor requires other protein regions for full DNA binding activity.
    Lu J; Sloan SR
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1521-8. PubMed ID: 11820794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimerization through the helix-loop-helix motif enhances phosphorylation of the transcription activation domains of myogenin.
    Zhou J; Olson EN
    Mol Cell Biol; 1994 Sep; 14(9):6232-43. PubMed ID: 8065355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein.
    Johanson M; Meents H; Ragge K; Buchberger A; Arnold HH; Sandmöller A
    Biochem Biophys Res Commun; 1999 Nov; 265(1):222-32. PubMed ID: 10548518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine (348) is a major determinant of the DNA binding specificity of transcription factor E12.
    Sieber M; Allemann RK
    Biol Chem; 1998 Jun; 379(6):731-5. PubMed ID: 9687024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.
    Schlaeger TM; Schuh A; Flitter S; Fisher A; Mikkola H; Orkin SH; Vyas P; Porcher C
    Mol Cell Biol; 2004 Sep; 24(17):7491-502. PubMed ID: 15314159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulation of selected bHLH proteins by eHAND.
    Bounpheng MA; Morrish TA; Dodds SG; Christy BA
    Exp Cell Res; 2000 Jun; 257(2):320-31. PubMed ID: 10837146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
    Valdez MR; Richardson JA; Klein WH; Olson EN
    Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the DNA-binding properties of MyoD, myogenin, and E12 by fluorescence anisotropy.
    Maleki SJ; Royer CA; Hurlburt BK
    Biochemistry; 2002 Sep; 41(35):10888-94. PubMed ID: 12196028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalently linking BHLH subunits of MASH-1 increases specificity of DNA binding.
    Künne AG; Allemann RK
    Biochemistry; 1997 Feb; 36(5):1085-91. PubMed ID: 9033398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamics of the DNA binding reaction of transcription factor MASH-1.
    K-unne AG; Sieber M; Meierhans D; Allemann RK
    Biochemistry; 1998 Mar; 37(12):4217-23. PubMed ID: 9521744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
    Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The semidominant Mi(b) mutation identifies a role for the HLH domain in DNA binding in addition to its role in protein dimerization.
    Steingrímsson E; Nii A; Fisher DE; Ferré-D'Amaré AR; McCormick RJ; Russell LB; Burley SK; Ward JM; Jenkins NA; Copeland NG
    EMBO J; 1996 Nov; 15(22):6280-9. PubMed ID: 8947051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
    Sauvé S; Tremblay L; Lavigne P
    J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis of the adenovirus type 2 E3/19K protein using mutagenesis and a panel of conformation-sensitive monoclonal antibodies.
    Menz B; Sester M; Koebernick K; Schmid R; Burgert HG
    Mol Immunol; 2008 Nov; 46(1):16-26. PubMed ID: 18692902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif.
    Maira SM; Wurtz JM; Wasylyk B
    EMBO J; 1996 Nov; 15(21):5849-65. PubMed ID: 8918463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.